Autophagy and the Science of Cellular Renewal

LONGEVITY LATEST | Deep Dive

DEEP DIVE

Autophagy and the Science of Cellular Renewal

How your cells take out the rubbish — and what happens when they stop

Longevity Latest | Issue 03 Companion | March 2026

Updated: March 2026

By the time you notice you’re ageing — the stiffness, the slower recovery, the brain fog — your cells have been accumulating damage for years. Misfolded proteins clump together. Mitochondria leak reactive oxygen species. Dysfunctional organelles pile up like unsorted waste in a recycling plant running at half capacity.

The recycling plant is autophagy (from the Greek auto, self, and phagein, to eat) — the process by which cells degrade and recycle their own damaged components. When it works, cells stay clean. When it declines, the consequences cascade: inflammation, neurodegeneration, metabolic dysfunction, cancer. Yoshinori Ohsumi won the 2016 Nobel Prize for identifying the genes that govern it. Since then, we’ve learned the machinery in remarkable detail — and we’re beginning to learn how to turn it back on.

How Autophagy Works

Autophagy operates through a tightly regulated molecular sequence. Every longevity intervention that targets autophagy acts on a specific step in this cascade.

The mTOR–AMPK Switch

The master regulator is mTORC1, a nutrient-sensing kinase that integrates signals about amino acids, growth factors, and energy status. When nutrients are abundant, mTORC1 promotes growth and protein synthesis while suppressing autophagy. When nutrients are scarce, mTORC1 is inhibited and the brake is released.

The counterbalance is AMPK, the cell’s energy sensor. When ATP drops — during fasting, exercise, or energy stress — AMPK activates and promotes autophagy directly. The mTOR–AMPK axis is the central toggle: mTOR says “grow,” AMPK says “repair.” Ageing tilts the balance toward chronic mTOR activation, even when repair is desperately needed.

Initiation: The ULK1 Complex

When mTORC1 is inhibited, it releases the ULK1 complex (ULK1, ATG13, FIP200, ATG101) — the ignition switch. ULK1 phosphorylates the PI3K complex (including beclin-1 and VPS34), generating a lipid signal (PI3P) that marks the site where the autophagosome — the double-membraned vesicle that engulfs the cargo — begins to form.

Engulfment and Degradation

The growing autophagosome wraps around its target. Two conjugation systems (ATG12–ATG5–ATG16L1 and LC3 lipidation) drive membrane expansion and sealing. Once sealed, the autophagosome fuses with a lysosome — an acidic compartment packed with degradative enzymes. The cargo is broken down into amino acids, lipids, and nucleotides, recycled into the cell’s biosynthetic pathways.

The Transcription Factor: TFEB

Autophagy is also regulated transcriptionally. TFEB controls dozens of autophagy and lysosomal genes. mTORC1 phosphorylates TFEB under nutrient-rich conditions, trapping it in the cytoplasm. When mTORC1 is inhibited, TFEB moves to the nucleus and switches on the entire autophagy–lysosomal programme — which is why mTOR inhibitors activate the system at both protein and transcriptional levels simultaneously.

Not All Autophagy Is the Same

The process above is macroautophagy — bulk clearance. But cells also run specialised recycling programmes targeting specific damage. These selective pathways are increasingly recognised as critical for ageing:

Mitophagy selectively removes damaged mitochondria. When a mitochondrion loses membrane potential, PINK1 and Parkin flag it for degradation. Failure leads to accumulation of leaky, ROS-producing mitochondria — a central driver of metabolic ageing, and the pathway connecting this issue’s theme to Issue 04’s mitochondrial focus.

Aggrephagy clears protein aggregates — the misfolded clumps of tau and amyloid-β that characterise neurodegenerative diseases. Lipophagy degrades intracellular lipid droplets, playing a key role in liver health and metabolic ageing.

Crucially, not all autophagy interventions activate all subtypes equally. Exercise is particularly potent for mitophagy. Spermidine’s neuroprotective signal may reflect aggrephagy. Matching the right intervention to the right pathway will be key to personalising longevity protocols.

Why Autophagy Declines with Age

Autophagic decline is now considered a primary hallmark of ageing. Several converging factors drive it:

Dysregulated nutrient sensing. With age, mTORC1 tends toward chronic activation even without genuine growth signals, suppressing ULK1 and trapping TFEB in the cytoplasm. Simultaneously, AMPK responsiveness declines — cells become slower to detect energy deficits and initiate repair. The result: the mTOR–AMPK toggle gets stuck in “grow” mode when it should be in “repair.”

Transcriptional decline. A 2025 review documented age-related declines in TFEB and FOXO transcription factor activity. The autophagy genes are still there — they’re just not being read efficiently.

Lysosomal dysfunction. Ageing lysosomes accumulate lipofuscin, become less acidic, and lose degradative capacity. Even when autophagosomes form, the incinerator is broken.

Interventions That Target Autophagy

Several interventions from this issue and previous issues target specific nodes in the pathway. Each acts at a different step:

Rapamycin (Issue 03, Grade C) inhibits mTORC1 directly, releasing both ULK1 and TFEB. The most potent pharmacological activator known, but immunosuppressive. PEARL trial (n=150): well-tolerated at low doses for one year.

Spermidine (Issue 03, Grade B) inhibits the acetyltransferase EP300. A 2024 Nature Cell Biology study confirmed it as an obligatory effector of fasting-induced autophagy. Epidemiological data (n=1,770) links dietary intake to reduced mortality.

Fasting suppresses mTOR and activates AMPK simultaneously. Bensalem et al. (2025, n=121): first direct human evidence that time-restricted eating increases autophagic flux.

Exercise activates AMPK, upregulates PGC-1α, and is particularly potent for mitophagy. The most accessible autophagy activator with the broadest evidence base.

Berberine (Issue 02 Spotlight) activates AMPK through non-mitochondrial pathways. Quercetin + dasatinib (Issue 03, Grade C) targets senescent cells — the downstream consequence when autophagy fails to clear damaged cells.

The Frontier

TFEB activation is emerging as a direct therapeutic target — upregulating the entire autophagy–lysosomal system without immunosuppression. Early compounds are in preclinical development.

The autophagy–glymphatic connection is another frontier. A January 2026 trial (n=39) confirmed sleep drives brain waste clearance. Intracellular autophagy and extracellular glymphatic clearance may be two arms of the same system. Reliable human autophagy biomarkers will be critical for proving whether enhancing either arm extends healthspan.

What This Means for You

You cannot measure your autophagic activity at home. But you can influence it:

Exercise regularly. Zone 2 cardio and resistance training. The single most potent autophagy activator available, with the broadest longevity evidence base.

Eat spermidine-rich foods. Wheat germ, aged cheese, mushrooms, soya beans. Compelling epidemiological data, safe, negligible cost.

Protect your sleep. 7–9 hours, prioritising deep slow-wave sleep. The glymphatic system clears brain waste almost exclusively while you sleep.

Don’t self-administer rapamycin or dasatinib. Both are potent pharmaceuticals with genuine risks. The evidence is not there yet for healthy adults.

Autophagy is not a quick fix. The Kiechl cohort followed people for 13 years before the mortality difference emerged. Bensalem found no change at two months; the signal appeared at six. The interventions that support autophagy are the ones that appear again and again in longevity research: move, eat whole foods rich in polyamines, sleep deeply, and resist buying what the evidence hasn’t yet earned. The cleaning crew works slowly. But it works.

Sources and Further Reading

Ohsumi, Y. (2014). Historical landmarks of autophagy research. Cell Research, 24(1), 9–23. Nobel Prize 2016.

Kim, Y. C. & Guan, K. L. (2015). mTOR: a pharmacologic target for autophagy regulation. Journal of Clinical Investigation, 125(1), 25–32. PMID: 25654547.

Hofer, S. J. et al. (2024). Spermidine is essential for fasting-mediated autophagy and longevity. Nature Cell Biology, 26(9), 1571–1584. PMID: 39117797.

Bensalem, J. et al. (2025). Intermittent time-restricted eating may increase autophagic flux in humans. The Journal of Physiology, 603(10), 3019–3032. PMID: 40345145.

Eisenberg, T. et al. (2009). Induction of autophagy by spermidine promotes longevity. Nature Cell Biology, 11, 1305–1314. PMID: 19801973.

Kiechl, S. et al. (2018). Higher spermidine intake is linked to lower mortality: a prospective population-based study. American Journal of Clinical Nutrition, 108(2), 371–380. PMID: 29955838.

Gkioni, L. et al. (2025). Rapamycin and trametinib combination extends lifespan in mice. Nature Aging. doi: 10.1038/s43587-025-00801-1.

Hands, J. M. et al. (2025). What is the clinical evidence to support off-label rapamycin therapy in healthy adults? Aging, 17(8). PMID: 40128001.

Dagum, P. et al. (2026). The glymphatic system clears amyloid beta and tau from brain to plasma in humans. Nature Communications. doi: 10.1038/s41467-026-68374-8.

Transcriptional dysregulation of autophagy in aging: TFEB and FOXOs. Frontiers in Bioscience, 30(9), 2025. doi: 10.31083/FBL38730.

Nedergaard, M. & Goldman, S. A. (2020). Glymphatic failure as a final common pathway to dementia. Science, 370(6512), 50–56. PMID: 33004510.

Aman, Y. et al. (2021). Autophagy in healthy aging and disease. Nature Aging, 1(8), 634–650. PMID: 37117848. [Comprehensive review of selective autophagy subtypes and ageing.]

This article is the companion Deep Dive to Longevity Latest Issue 03. Subscribe to receive the newsletter every week.

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new supplement, medication, or health protocol. Rapamycin and dasatinib are prescription medications with significant side effects and should only be used under medical supervision.

© 2026 Longevity Latest | Deep Dive: Autophagy and the Science of Cellular Renewal | Issue 03 Companion